Northern Trust
OLMA icon

Northern Trust’s Olema Pharmaceuticals OLMA Stock Holding History

Northern Trust’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44M Buy
674,945
+104,989
+18% +$1.41M ﹤0.01% 2302
2026
Q1 		$8.5M Buy
569,956
+124,629
+28% +$2.77M ﹤0.01% 2161
2025
Q4 		$11.1M Sell
445,327
-37,705
-8% -$671K ﹤0.01% 2024
2025
Q3 		$4.73M Sell
483,032
-16,392
-3% -$98.4K ﹤0.01% 2534
2025
Q2 		$2.13M Buy
499,424
+81,339
+19% +$363K ﹤0.01% 2945
2025
Q1 		$1.57M Sell
418,085
-5,702
-1% -$28.7K ﹤0.01% 3048
2024
Q4 		$2.47M Buy
423,787
+34,053
+9% +$340K ﹤0.01% 2904
2024
Q3 		$4.65M Buy
389,734
+45,652
+13% +$584K ﹤0.01% 2519
2024
Q2 		$3.72M Sell
344,082
-5,075
-1% -$55K ﹤0.01% 2557
2024
Q1 		$3.95M Sell
349,157
-3,661
-1% -$47.2K ﹤0.01% 2609
2023
Q4 		$4.95M Buy
352,818
+51,493
+17% +$692K ﹤0.01% 2525
2023
Q3 		$3.72M Buy
301,325
+6,569
+2% +$67K ﹤0.01% 2613
2023
Q2 		$2.66M Buy
294,756
+221,764
+304% +$1.34M ﹤0.01% 2842
2023
Q1 		$253K Buy
72,992
+5,374
+8% +$21.9K ﹤0.01% 3748
2022
Q4 		$166K Sell
67,618
-117
-0.2% -$341 ﹤0.01% 3946
2022
Q3 		$187K Buy
67,735
+7,535
+13% +$32K ﹤0.01% 3902
2022
Q2 		$245K Sell
60,200
-170,683
-74% -$541K ﹤0.01% 3816
2022
Q1 		$983K Sell
230,883
-20,225
-8% -$111K ﹤0.01% 3422
2021
Q4 		$2.35M Buy
251,108
+4,843
+2% +$100K ﹤0.01% 3145
2021
Q3 		$6.79M Buy
246,265
+112,823
+85% +$3.05M ﹤0.01% 2543
2021
Q2 		$3.73M Buy
133,442
+3,334
+3% +$94.9K ﹤0.01% 3011
2021
Q1 		$4.32M Buy
130,108
+116,206
+836% +$4.98M ﹤0.01% 2843
2020
Q4 		$668K Buy
+13,902
New +$652K ﹤0.01% 3645

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Northern Trust's OLMA Position: Q2 2026 in Review

Northern Trust increased its Olema Pharmaceuticals (OLMA) stake by 18% in Q2 2026, buying an estimated $1.41M and bringing the position to 674,945 shares worth $8.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Northern Trust first reported a position in OLMA in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.1M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Northern Trust held 674,945 shares of Olema Pharmaceuticals worth $8.44M as of Q2 2026.
  • Northern Trust bought 104,989 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.41M.
  • Olema Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2302 holding.
  • Northern Trust first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Northern Trust's Olema Pharmaceuticals position peaked at $11.1M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.